RethinkPeptides
ArticlesTopicsResearch

GnRH and Endometriosis

3 articles in this topic.

Complete Guides

GnRH and EndometriosisGuide

GnRH Agonists for Endometriosis: How Suppression Treats Pain

GnRH agonists treat endometriosis by suppressing estrogen via pituitary downregulation. Pain relief in 50-90% of patients but bone loss limits monotherapy.

19 min read|Mar 20, 2026

All Articles

GnRH and Endometriosis

Peptide Approaches to Endometriosis Treatment

GnRH peptide agonists and oral antagonists for endometriosis pain, what clinical trials show for elagolix and relugolix, and emerging peptide targets.

13 min read|Mar 25, 2026
GnRH and Endometriosis

Elagolix and Relugolix: Oral GnRH Antagonists

Elagolix and relugolix are oral GnRH antagonists for endometriosis pain. We compare their Phase 3 trial data, bone density effects, and dosing tradeoffs.

12 min read|Mar 21, 2026

RethinkPeptides

Evidence-based peptide education. No hype, no sales. Just science.

Navigate

All ArticlesTopicsResearch DatabaseEvidence MethodologyDownload DataSearch

About

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of Use

Disclaimer

Content on RethinkPeptides is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Peptides discussed here may not be approved for human use in your jurisdiction.

© 2026 RethinkPeptides. All rights reserved.